These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1312 related articles for article (PubMed ID: 22449442)
1. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response. Cui B; Sun JH; Xiang FF; Liu L; Li WJ Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442 [TBL] [Abstract][Full Text] [Related]
2. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009 [TBL] [Abstract][Full Text] [Related]
3. High-salt loading exacerbates increased retinal content of aquaporins AQP1 and AQP4 in rats with diabetic retinopathy. Qin Y; Xu G; Fan J; Witt RE; Da C Exp Eye Res; 2009 Nov; 89(5):741-7. PubMed ID: 19596320 [TBL] [Abstract][Full Text] [Related]
4. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Tamura H; Miyamoto K; Kiryu J; Miyahara S; Katsuta H; Hirose F; Musashi K; Yoshimura N Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1440-4. PubMed ID: 15790913 [TBL] [Abstract][Full Text] [Related]
5. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo. Hattori T; Matsubara A; Taniguchi K; Ogura Y Curr Eye Res; 2010 Feb; 35(2):146-54. PubMed ID: 20136425 [TBL] [Abstract][Full Text] [Related]
6. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model. Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451 [TBL] [Abstract][Full Text] [Related]
7. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina. Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of the atrial natriuretic peptide/natriuretic peptide receptor-C system in the early stages of diabetic retinopathy in the rat. Rollín R; Mediero A; Fernández-Cruz A; Fernández-Durango R Mol Vis; 2005 Mar; 11():216-24. PubMed ID: 15789000 [TBL] [Abstract][Full Text] [Related]
9. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. Barber AJ; Antonetti DA; Gardner TW Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253 [TBL] [Abstract][Full Text] [Related]
10. Expression of aquaporin 4 and Kir4.1 in diabetic rat retina: treatment with minocycline. Zhang Y; Xu G; Ling Q; Da C J Int Med Res; 2011; 39(2):464-79. PubMed ID: 21672350 [TBL] [Abstract][Full Text] [Related]
11. Protective effects of a coumarin derivative in diabetic rats. Bucolo C; Ward KW; Mazzon E; Cuzzocrea S; Drago F Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3846-52. PubMed ID: 19279317 [TBL] [Abstract][Full Text] [Related]
12. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy. Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488 [TBL] [Abstract][Full Text] [Related]
14. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes. Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967 [TBL] [Abstract][Full Text] [Related]
15. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats. Mitsuhashi J; Morikawa S; Shimizu K; Ezaki T; Yasuda Y; Hori S Exp Eye Res; 2013 Jan; 106():64-73. PubMed ID: 23178551 [TBL] [Abstract][Full Text] [Related]
17. Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats. Kumar B; Gupta SK; Srinivasan BP; Nag TC; Srivastava S; Saxena R; Jha KA Microvasc Res; 2013 May; 87():65-74. PubMed ID: 23376836 [TBL] [Abstract][Full Text] [Related]
18. Implication of VEGF and aquaporin 4 mediating Müller cell swelling to diabetic retinal edema. Kida T; Oku H; Horie T; Fukumoto M; Okuda Y; Morishita S; Ikeda T Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1149-1157. PubMed ID: 28303331 [TBL] [Abstract][Full Text] [Related]
19. Glial reactivity, an early feature of diabetic retinopathy. Rungger-Brändle E; Dosso AA; Leuenberger PM Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1971-80. PubMed ID: 10845624 [TBL] [Abstract][Full Text] [Related]
20. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina. Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]